Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1(RS)-baclofen, naltrexone hydrochloride and D-sorbitol
(D02095)
[3] Baclofen,
Naltrexone,
Sorbitol
[4] Sorbitol solution ,
Baclofen ,
Naltrexone hydrochloride (D02095),
Naltrexone 💬
[5] GABBR1,
GABBR2,
OPRD1,
OPRK1,
OPRM1 💬
[11] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 10 💬
24.5 mg Naltrexone
(D02095)
[1] Naltrexone[2] Naltrexone hydrochloride (D02095),
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
3Low dose naltrexone
(D02095)
[1] Naltrexone[2] Naltrexone hydrochloride (D02095),
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 96, 97 💬
4Low-dose naltrexone
(D02095)
[1] Naltrexone[2] Naltrexone hydrochloride (D02095),
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
5Low-Dose Naltrexone (LDN)
(D02095)
[1] Naltrexone[2] Naltrexone hydrochloride (D02095),
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[3] 13, 46, 49 💬
6NALTREXONE
(D02095)
[1] Naltrexone[2] Naltrexone hydrochloride (D02095),
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[14] 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
7NALTREXONE CLORIDRATO
(D02095)
[1] Naltrexone[2] Naltrexone hydrochloride (D02095),
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 10 💬
8NALTREXONE HYDROCHLORIDE
(D02095)
[1] Naltrexone[2] Naltrexone hydrochloride (D02095),
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[9] 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
9Naltrexone-HCl
(D02095)
[1] Naltrexone[2] Naltrexone hydrochloride (D02095),
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 96 💬